Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
Regeneron registers Phase 1b hemodialysis study, Phase 1 Graves' disease trialOct 9Weekly roundup, 6 itemsamrecibartbortezomib
FDA approves Bristol Myers Squibb's Zenbexus, a new molecular entityAug 13Regulatory decisionBristol Myers Squibbiberdomide
Results post for old USC gastric cancer trial; Bristol Myers Squibb opens new Zeposia PML studyJul 30Weekly roundup, 3 itemsBristol Myers Squibbiberdomide